A Korean stem cell journal has retracted a paper on a controversial Italian treatment that involves harvesting stem cells from bone marrow and injecting them back into the patient.
“Stamina therapy” has been pitched as a treatment for everything from Parkinson’s disease to coma, based on a U.S. patent application filed in 2010. The Italian government pledged about $3.9 million in 2013 to support a clinical trial for stamina therapy. More than 100 people signed up for the trials, with a wide range of neurological ailments; half were children.
However, allegations of fraud led to a criminal investigation into the Stamina Foundation’s leader, psychologist David Vannoni, as well as 17 other members of the organization. Continue reading Paper on controversial stem cell “stamina therapy” retracted